Coeptis Therapeutics (COEPW) Competitors $0.02 -0.01 (-22.26%) Closing price 03:58 PM EasternExtended Trading$0.03 +0.00 (+20.66%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock COEPW vs. ATNFW, SXTPW, DRTSW, APLMW, BCTXW, CDIOW, CELUW, CEROW, CINGW, and CLNNWShould you be buying Coeptis Therapeutics stock or one of its competitors? The main competitors of Coeptis Therapeutics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), and Clene (CLNNW). These companies are all part of the "biotechnology" industry. Coeptis Therapeutics vs. Its Competitors 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Celularity CERo Therapeutics Cingulate Clene 180 Life Sciences (NASDAQ:ATNFW) and Coeptis Therapeutics (NASDAQ:COEPW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings. Is ATNFW or COEPW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Coeptis Therapeutics N/A N/A N/A Does the media prefer ATNFW or COEPW? In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Coeptis Therapeutics'average media sentiment score. Company Overall Sentiment 180 Life Sciences Neutral Coeptis Therapeutics Neutral Which has higher earnings and valuation, ATNFW or COEPW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ACoeptis Therapeutics$263.56KN/AN/AN/AN/A SummaryCoeptis Therapeutics beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Get Coeptis Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for COEPW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COEPW vs. The Competition Export to ExcelMetricCoeptis TherapeuticsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$137.77M$5.76B$9.72BDividend YieldN/A3.74%4.40%4.10%P/E RatioN/A3.8830.1925.84Price / SalesN/A4,065.03473.64122.75Price / CashN/A13.1925.7828.79Price / BookN/A47.799.425.99Net IncomeN/A-$90.99M$3.27B$265.29M7 Day PerformanceN/A6.90%2.05%2.53%1 Month PerformanceN/A8.88%3.58%0.93%1 Year PerformanceN/A210.57%30.09%18.70% Coeptis Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COEPWCoeptis TherapeuticsN/A$0.02-22.3%N/A+41.5%$0.00$263.56K0.004Gap DownATNFW180 Life SciencesN/A$0.27-16.0%N/A+2,400.6%$0.00N/A0.007Gap DownHigh Trading VolumeSXTPW60 Degrees PharmaceuticalsN/A$0.11flatN/A+174.3%$0.00$641.41K0.002Positive NewsDRTSWAlpha Tau MedicalN/A$0.30+8.5%N/AN/A$0.00N/A0.0080APLMWApollomicsN/A$0.02-4.5%N/A+24.9%$0.00N/A0.0059Positive NewsGap DownBCTXWBriaCell TherapeuticsN/A$0.02-14.6%N/A-92.1%$0.00N/A0.008Gap DownCDIOWCardio DiagnosticsN/A$0.01+4.4%N/A-59.4%$0.00$19.51K0.007Positive NewsCELUWCelularityN/A$0.04-30.1%N/AN/A$0.00$54.22M0.00220Positive NewsGap UpCEROWCERo TherapeuticsN/A$0.01+14.6%N/AN/A$0.00N/A0.008Gap UpCINGWCingulateN/A$0.05-0.4%N/A-22.0%$0.00N/A0.0020Gap UpCLNNWCleneN/A$0.04+7.4%N/AN/A$0.00$286K0.00100Gap Up Related Companies and Tools Related Companies ATNFW Competitors SXTPW Competitors DRTSW Competitors APLMW Competitors BCTXW Competitors CDIOW Competitors CELUW Competitors CEROW Competitors CINGW Competitors CLNNW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:COEPW) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coeptis Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coeptis Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access